MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Reliant Technologies, Inc., the pioneer of fractional skin resurfacing and market leader in aesthetic medicine, today announced that its Fraxel re:pair laser system has received the industry’s only FDA 510(K) clearance for a fractional ablative laser system for treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions and vascular dyschromia. The Fraxel re:pair system, initially cleared for ablation, coagulation and skin resurfacing in May, 2007, becomes the only fractional ablative resurfacing system cleared by the FDA for specific indications of use.
